Internal Medicine, Endocrinology, Diabetes, & Metabolism · North Port, FL
NPI
1639613300
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
18669 Tamiami Trl Ste B
North Port, FL, 34287
Phone (941) 423-5040
Groups this clinician bills Medicare through
Medicare paid, 2024
$175K
4,698 services
Medicare patients, 2024
580
Average age 73
Drug cost, 2024
$9.0M
7,137 prescriptions
Company payments, 2025
$2,133
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kalyani Regeti was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 893 times for 504 patients. In total Kalyani Regeti billed 4,698 services in 49 codes, and Medicare paid $175K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 893 | 504 | $12.70 | $11K |
| 99214 Office E&M - Established | Office | 706 | 413 | $90.89 | $64K |
| 95251 Test - Miscellaneous | Office | 532 | 214 | $25.50 | $14K |
| 36415 Venipuncture Blood Collection | Office | 341 | 222 | $8.62 | $2,941 |
| 80053 Clinical Chemistry | Office | 246 | 155 | $10.31 | $2,536 |
| 99215 Office E&M - Established | Office | 236 | 168 | $133.81 | $32K |
| 82962 Clinical Chemistry | Office | 219 | 149 | $3.18 | $697 |
| 83036 Blood Count | Office | 213 | 130 | $9.48 | $2,020 |
| 82043 Clinical Chemistry | Office | 157 | 113 | $5.66 | $889 |
| 82570 Clinical Chemistry | Office | 157 | 113 | $5.08 | $798 |
| 80061 Clinical Chemistry | Office | 147 | 115 | $13.12 | $1,929 |
| 99205 Office E&M - New | Office | 119 | 119 | $148.61 | $18K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 105 | 21 | $4.92 | $517 |
| 84443 Clinical Chemistry | Office | 90 | 66 | $16.46 | $1,481 |
| 84439 Clinical Chemistry | Office | 89 | 65 | $8.84 | $787 |
By year: 2022 $147K for 3,226 services; 2023 $151K for 3,408 services; 2024 $175K for 4,698 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 341 | 222 | $8.62 | $2,941 |
| 80053 Clinical Chemistry | 246 | 155 | $10.31 | $2,536 |
| 82962 Clinical Chemistry | 219 | 149 | $3.18 | $697 |
| 83036 Blood Count | 213 | 130 | $9.48 | $2,020 |
| 82043 Clinical Chemistry | 157 | 113 | $5.66 | $889 |
| 82570 Clinical Chemistry | 157 | 113 | $5.08 | $798 |
| 80061 Clinical Chemistry | 147 | 115 | $13.12 | $1,929 |
| 84443 Clinical Chemistry | 90 | 66 | $16.46 | $1,481 |
| 84439 Clinical Chemistry | 89 | 65 | $8.84 | $787 |
| 84481 Clinical Chemistry | 41 | 27 | $16.60 | $681 |
Medicare prescription drug claims, 2024
In 2024, the drug Kalyani Regeti prescribed most often to Medicare patients was Ozempic (Semaglutide), with 903 prescriptions and refills. In total Kalyani Regeti wrote 7,137 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 903 | 1,804 | 233 | $1.8M |
| Mounjaro Tirzepatide | 892 | 1,331 | 170 | $1.4M |
| Levothyroxine Sodium Generic | 474 | 1,399 | 169 | $4,576 |
| Farxiga Dapagliflozin Propanediol | 401 | 932 | 109 | $513K |
| Tresiba Flextouch U-200 Insulin Degludec | 275 | 731 | 94 | $358K |
| Jardiance Empagliflozin | 268 | 661 | 82 | $382K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 253 | 680 | 72 | $581K |
| Metformin Hcl Generic | 217 | 625 | 83 | $1,220 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 206 | 583 | 69 | $375K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 203 | 440 | 76 | $21K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 191 | 522 | 89 | $265K |
| Tresiba Flextouch U-100 Insulin Degludec | 166 | 477 | 63 | $159K |
| Kerendia Finerenone | 143 | 308 | 32 | $191K |
| Methimazole Generic | 139 | 417 | 46 | $1,613 |
| Atorvastatin Calcium Generic | 128 | 329 | 45 | $769 |
Brand drugs: 5,107 claims; generic drugs: 1,255 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kalyani Regeti $2,133 ($2,133 in general payments such as food, travel and fees) from 27 companies. The largest payer was Corcept Therapeutics with $386.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 25 | $386 |
| Novo Nordisk Inc NVO | 16 | $318 |
| Amgen Inc. AMGN | 4 | $162 |
| Abbott Laboratories ABT | 2 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $120 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $120 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $113 |
| Insulet Corporation PODD | 3 | $90.81 |
| Recordati_rare_diseases_inc. | 3 | $83.63 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $70.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.